Wei Feng

Wei Feng is a seasoned professional with extensive expertise in early cancer detection and immunoassay optimization, currently serving as a Director at Alamar Biosciences, Inc. since December 2018. Wei has held various roles at the company, including Group Lead, Senior Scientist II, and Scientist, focusing on qPCR, NGS sequencing, and protein conjugation. Prior to that, a Postdoctoral Research Fellow position at the Carnegie Institution for Science was held from October 2014 to December 2018, where research involved studying cellular changes in plants under salt stress with a novel live imaging system. Wei's academic background includes a Graduate Student Researcher role at Indiana University Bloomington, where research concentrated on DNA damage-induced nuclear body formation, and a Bachelor's degree in Biology from Tsinghua University.